CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,048
- in 4 filings
Net −$177,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-02 | French Glendon E. III President and CEO | Sale | −13,511 | $1.57 | $21K | 1,178,162 |
| 2026-06-01 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sale | −2,691 | $1.54 | $4K | 343,045 |
| 2026-06-01 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sale | −2,153 | $1.54 | $3K | 340,892 |
| 2026-06-01 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sale | −3,684 | $1.54 | $6K | 337,208 |
| 2026-06-01 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sale | −5,969 | $1.54 | $9K | 331,239 |
| 2026-06-01 | French Glendon E. III President and CEO | Sale | −4,171 | $1.54 | $6K | 1,230,140 |
| 2026-06-01 | French Glendon E. III President and CEO | Sale | −38,467 | $1.54 | $59K | 1,191,673 |
| 2026-06-01 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −1,778 | $1.54 | $3K | 463,956 |
| 2026-06-01 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −1,557 | $1.54 | $2K | 462,399 |
| 2026-06-01 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −2,434 | $1.54 | $4K | 459,965 |
| 2026-06-01 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −2,254 | $1.54 | $3K | 457,711 |
| 2026-06-01 | Lehman David Aaron GENERAL COUNSEL | Sale | −3,876 | $1.54 | $6K | 386,879 |
| 2026-06-01 | Lehman David Aaron GENERAL COUNSEL | Sale | −2,264 | $1.54 | $3K | 384,615 |
| 2026-06-01 | Lehman David Aaron GENERAL COUNSEL | Sale | −3,539 | $1.54 | $5K | 381,076 |
| 2026-06-01 | Lehman David Aaron GENERAL COUNSEL | Sale | −4,915 | $1.54 | $8K | 376,161 |
| 2026-03-02 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sale | −756 | $1.43 | $1K | 180,463 |
| 2026-03-02 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sale | −3,068 | $1.43 | $4K | 177,395 |
| 2026-03-02 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sale | −2,461 | $1.43 | $4K | 174,934 |
| 2026-03-02 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sale | −4,198 | $1.43 | $6K | 170,736 |
| 2026-03-02 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Grant or award | +175,000 | 345,736 |
Page 2 of 12 · 235 trades